I’ve never much thought about what goes into the little white tablet I swallow when I’m hungover, have the sniffles or another bout of Geek’s Disease.* It’s just chalky magic, right? Well, no: it’s the result of millions of dollars, aggressive R&D, production facilities of breathtaking size and precision, ruthless marketeering and impossibly sinister downplaying and mitigation of side effects. While medicine-themed management game Big Pharma doesn’t go for pharmaceutical industry’s jugular, Goldacre-style, its pills-as-merciless-industry approach is certainly a welcome change from the bland, smiling, comfortable faces that advertising tells us medicine are all about.
Read the rest of this entry »